ArticleApplied biochemistry and biotechnology2026
Comparative Therapeutic Effects of Lipid-Enriched and Ethanolic Garlic Extracts on DMBA-Induced Hepatic Carcinogenesis in Mice.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Garlic (Allium sativum) contains bioactive components with antioxidants and anti-inflammatory constituents with potential anticancer activity. We aimed to compare a petroleum-ether garlic extract (PEGE) versus an ethanolic garlic extract (EGE) in a DMBA-induced murine hepatic carcinogenesis model. Fresh garlic was extracted with petroleum ether or ethanol and chemically characterized by GC-MS. PEGE was enriched in long-chain fatty acids/derivatives, while EGE contained both lipids and more polar constituents. Male Swiss albino mice received DMBA and were assigned to concurrent (DMBA + extract) or post-DMBA (DMBA → extract) regimens; extract-only and vehicle groups served as toxicity controls. Biochemical parameters (ALT, AST, AFP), oxidative stress markers (MDA, GSH), inflammatory signaling (NF-κB by ELISA), apoptosis (caspase-3 gene expression by qPCR), proliferation (PCNA by flow cytometry), and histopathological changes (H&E staining) were evaluated. Extract-only showed no significant differences compared to control groups, indicating no overt toxicity. DMBA administration resulted in significant hepatic injury, evidenced by elevated liver enzymes and AFP, increased lipid peroxidation and NF-κB levels, depleted GSH, enhanced cellular proliferation, and severe histopathological alterations. Across endpoints, the post-DMBA PEGE regimen produced the largest overall normalization, followed by EGE. Post-treatment outperforming concurrent dosing for both extracts. Histology aligned the biochemical trends, showing reduced necrosis, inflammation, vascular congestion, and dysplastic changes in treated groups. Both garlic extracts showed hepatoprotective effects in this preclinical model; they were well tolerated and mitigated DMBA-induced injury, with PEGE given after DMBA yielding the strongest biochemical, molecular, and histopathological improvements. Chemical differences between the lipid-rich PEGE and the more polar EGE likely contribute to their differential efficacy and merit further standardization and mechanistic study.
Indexed as
Identifiers
42684663What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.